Brief: Lee's Pharmaceutical Holdings Says Co Decides To Implement Share Repurchase Program Of Up To 30 Mln Shares
02/09/2019 14:31
Sept 2 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* CO DECIDED TO IMPLEMENT A SHARE REPURCHASE PROGRAM OF UP
TO 30
MILLION SHARES
* LEE'S PHARMACEUTICAL - AGGREGATE AMOUNT OF FUNDS INTENDED
TO BE
USED FOR PROPOSED SHARE REPURCHASE UP TO HK$120 MILLION
Source text for Eikon: ID:nHKS1nmLLg
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA